Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pro Dex (PDEX) Shares Outstanding (2016 - 2025)

Pro Dex (PDEX) has disclosed Shares Outstanding for 14 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 1.55% to $3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 1.55% year-over-year, with the annual reading at $3.3 million for FY2025, 3.04% down from the prior year.
  • Shares Outstanding hit $3.2 million in Q4 2025 for Pro Dex, down from $3.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $3.7 million in Q1 2021 to a low of $3.2 million in Q4 2025.
  • Historically, Shares Outstanding has averaged $3.5 million across 5 years, with a median of $3.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: decreased 0.36% in 2023 and later decreased 7.93% in 2024.
  • Year by year, Shares Outstanding stood at $3.6 million in 2021, then dropped by 2.42% to $3.6 million in 2022, then decreased by 0.36% to $3.5 million in 2023, then dropped by 7.93% to $3.3 million in 2024, then decreased by 1.55% to $3.2 million in 2025.
  • Business Quant data shows Shares Outstanding for PDEX at $3.2 million in Q4 2025, $3.3 million in Q3 2025, and $3.3 million in Q2 2025.